Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek L Chappell

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|July 26, 2011
Development and validation of a LC/MS/MS method for 6-keto PGF1α, a metabolite of prostacyclin (PGI₂)Derek L Chappell, Xiaoyao Xiao, Waldemar Radziszewski, et al.
Bioanalysis|December 11, 2012
Development and validation of an ultra-sensitive method for the measurement of plasma renin activity in human plasma via LC-MS/MSDerek L Chappell, Thomas McAvoy, Barbra Weiss, et al.
Bioanalysis|October 8, 2016
Development and validation of an IA-LC/MS method to quantitate active and total B-type natriuretic peptide in human plasmaDerek L Chappell, Anita Yh Lee, Harold S Bernstein, et al.
Bioanalysis|August 27, 2014
Quantitation of human peptides and proteins via MS: review of analytically validated assaysDerek L Chappell, Michael E Lassman, Thomas McAvoy, et al.
Bioanalysis|July 12, 2016
An evaluation of an aptamer for use as an affinity reagent with MS: PCSK9 as an example proteinVinita Gupta, Michael E Lassman, Thomas McAvoy, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 5, 2016
The clinical utility of mass spectrometry based protein assaysMichael E Lassman, Thomas McAvoy, Derek L Chappell, et al.
Clinical Pharmacology and Therapeutics|December 6, 2020
Experimental Medicine Study to Measure Immune Checkpoint Receptors PD-1 and GITR Turnover Rates In Vivo in HumansMichael E Lassman, Derek L Chappell, Thomas McAvoy, et al.
Bioanalysis|December 18, 2013
An ultrasensitive method for the quantitation of active and inactive GLP-1 in human plasma via immunoaffinity LC-MS/MSDerek L Chappell, Anita Yh Lee, Jose Castro-Perez, et al.
Journal of Clinical Pharmacology|April 25, 2008
Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjectsJules I Schwartz, Aimee L Dallob, Patrick J Larson, et al.
Clinical Chemistry|October 3, 2015
Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry after a Meal Tolerance TestAnita Y H Lee, Derek L Chappell, Monika J Bak, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Pharmaceutical and Biomedical Analysis|July 26, 2011
Development and validation of a LC/MS/MS method for 6-keto PGF1α, a metabolite of prostacyclin (PGI₂)Derek L Chappell, Xiaoyao Xiao, Waldemar Radziszewski, et al.
Bioanalysis|December 11, 2012
Development and validation of an ultra-sensitive method for the measurement of plasma renin activity in human plasma via LC-MS/MSDerek L Chappell, Thomas McAvoy, Barbra Weiss, et al.
Bioanalysis|October 8, 2016
Development and validation of an IA-LC/MS method to quantitate active and total B-type natriuretic peptide in human plasmaDerek L Chappell, Anita Yh Lee, Harold S Bernstein, et al.
Bioanalysis|August 27, 2014
Quantitation of human peptides and proteins via MS: review of analytically validated assaysDerek L Chappell, Michael E Lassman, Thomas McAvoy, et al.
Bioanalysis|July 12, 2016
An evaluation of an aptamer for use as an affinity reagent with MS: PCSK9 as an example proteinVinita Gupta, Michael E Lassman, Thomas McAvoy, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 5, 2016
The clinical utility of mass spectrometry based protein assaysMichael E Lassman, Thomas McAvoy, Derek L Chappell, et al.
Clinical Pharmacology and Therapeutics|December 6, 2020
Experimental Medicine Study to Measure Immune Checkpoint Receptors PD-1 and GITR Turnover Rates In Vivo in HumansMichael E Lassman, Derek L Chappell, Thomas McAvoy, et al.
Bioanalysis|December 18, 2013
An ultrasensitive method for the quantitation of active and inactive GLP-1 in human plasma via immunoaffinity LC-MS/MSDerek L Chappell, Anita Yh Lee, Jose Castro-Perez, et al.
Journal of Clinical Pharmacology|April 25, 2008
Comparative inhibitory activity of etoricoxib, celecoxib, and diclofenac on COX-2 versus COX-1 in healthy subjectsJules I Schwartz, Aimee L Dallob, Patrick J Larson, et al.
Clinical Chemistry|October 3, 2015
Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry after a Meal Tolerance TestAnita Y H Lee, Derek L Chappell, Monika J Bak, et al.
Pageof 2